A restrospective study to assess patterns and outcomes of ranibizumab dosing regimen in patients with age-related macular degeneration
Latest Information Update: 05 Nov 2016
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2016 New trial record